The lower perfusion in tumour vs normal kidney also contrasts with the observation that levels of the potent proangiogenic protein, vascular endothelial growth factor (VEGF), are 3–37 times greater in renal cancer compared to normal parenchyma (Brown et al, 1993). The gene discussed is VEGFA; the disease is renal carcinoma.